These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 4510913)

  • 1. Permanently successful chemotherapy in two cases with severe pulmonary mycobacterial disease due to Mycobacterium kansasii and fortuitum, respectively.
    Radenbach KL
    Scand J Respir Dis Suppl; 1972; 80():23-7. PubMed ID: 4510913
    [No Abstract]   [Full Text] [Related]  

  • 2. A ten-year clinical experience with Mycobacterium kansasii.
    Rauscher CR; Kerby G; Ruth WE
    Chest; 1974 Jul; 66(1):17-9. PubMed ID: 4846114
    [No Abstract]   [Full Text] [Related]  

  • 3. Mycobacterium fortuitum infections: a review with two illustrative cases.
    Halpern AA; Nagel DA
    Clin Orthop Relat Res; 1978 Oct; (136):247-52. PubMed ID: 729293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug therapy of resistant cases of pulmonary tuberculosis in Indian patients.
    Mital OP; Agarwala MC; Singh SK
    Indian J Chest Dis; 1967 Oct; 9(4):196-206. PubMed ID: 4323543
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lung diseases due to atypical mycobacteria].
    Favez G
    Schweiz Med Wochenschr; 1975 Aug; 105(31):987-91. PubMed ID: 1153999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy of so-called atypical mycobacterioses].
    Rosenfeld M
    Beitr Klin Erforsch Tuberk Lungenkr; 1968; 137(2):115-29. PubMed ID: 4195733
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycobacterium kansasii in East Kent. A report of seven pulmonary infections with an environmental study.
    Jones JS
    Br J Dis Chest; 1969 Apr; 63(2):83-95. PubMed ID: 5771897
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycobacterium simiae Infection in an Immunocompromised Patient without Acquired Immunodeficiency Syndrome.
    Braun-Saro B; Esteban J; Jiménez S; Castrillo JM; Fernández-Guerrero ML
    Clin Infect Dis; 2002 Mar; 34(5):E26-7. PubMed ID: 11810603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated infection caused by Mycobacterium kansasii. Report of a case and brief review of the literature.
    Hagmar B; Kutti J; Lundin P; Norlin M; Weinfeld A; Wåhlén P
    Acta Med Scand; 1969; 186(1-2):93-9. PubMed ID: 4185322
    [No Abstract]   [Full Text] [Related]  

  • 10. Status of mycobacterial infections of the lungs.
    Savacool JW
    Ann Clin Lab Sci (1971); 1973; 3(2):91-7. PubMed ID: 4575158
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical significance of Mycobacterium fortuitum infections in pulmonary disease.
    Awe RJ; Gangadharam PR; Jenkins DE
    Am Rev Respir Dis; 1973 Nov; 108(5):1230-4. PubMed ID: 4746583
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 13. [Atypical mycobacterial infection due to Mycobacterium fortuitum].
    Wegmann T; Jutz P; Pagon S
    Schweiz Med Wochenschr; 1978 May; 108(18):684-6. PubMed ID: 77556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pulmonary infection by mycobacterium fortuitum].
    Quibant M; Molina C; Cluzel R; Sirot J; Cluzel M; Michel J
    Rev Tuberc Pneumol (Paris); 1969; 33(3):381-91. PubMed ID: 5383008
    [No Abstract]   [Full Text] [Related]  

  • 15. Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis.
    Sanguinetti M; Ardito F; Fiscarelli E; La Sorda M; D'Argenio P; Ricciotti G; Fadda G
    J Clin Microbiol; 2001 Feb; 39(2):816-9. PubMed ID: 11158161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and long-term follow-up of patients with atypical mycobacterial infections.
    Davidson PT
    Bull Int Union Tuberc; 1976; 51(1):257-61. PubMed ID: 1030293
    [No Abstract]   [Full Text] [Related]  

  • 17. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S
    Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycobacterium szulgai; a new pathogen causing infection of the lung.
    Davidson PT
    Chest; 1976 Jun; 69(6):799-801. PubMed ID: 1277906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical aspects of atypical mycobacterial infection.
    Kahana LM; Cole FM; Richardson H
    Can Med Assoc J; 1975 Feb; 112(3):321-4. PubMed ID: 1109749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Mycobacterium scrofulaceum infection in a child.
    Cooper AR; Martin RS
    Pediatrics; 1972 Jan; 49(1):118-24. PubMed ID: 5059291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.